10:18 AM EST - Microbix Biosystems Inc. : Is presenting results of its use of Microbix Quality Assessment Products for accreditation of clinical labs for conducting molecular tests for antimicrobial-resistant strains of M. genitalium, a common sexually-transmitted infection. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.34.
